Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.
about
Recombinant factor VIIa use in patients presenting with intracranial hemorrhage.Progressing haemorrhagic stroke: categories, causes, mechanisms and managements.The fibrinogen but not the Factor VIII content of transfused plasma determines its effectiveness at reducing bleeding in coagulopathic mice.Treatment with FTY720 has no beneficial effects on short-term outcome in an experimental model of intracerebral hemorrhage.Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studiesImaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.Anticoagulation-related intracranial hemorrhages.Intracerebral hemorrhage in patients receiving oral anticoagulation therapy.The Pathophysiology of Intracerebral Hemorrhage Formation and Expansion.Retrospective study of rFVIIa, 4-factor PCC, and a rFVIIa and 3-factor PCC combination in improving bleeding outcomes in the warfarin and non-warfarin patient.Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate.Warfarin pretreatment reduces cell death and MMP-9 activity in experimental intracerebral hemorrhage.
P2860
Q34135771-62343CE8-0BE8-4E8E-BFE4-BA4CB118F220Q34459723-EA7D883D-3375-4D1C-B0DA-DDB72161F0D9Q35430725-D1795620-5EF8-4AF1-ABDD-91FC846ED5C4Q36591931-A70876B7-5385-4BEF-AF43-D2BD6A1E0990Q36984232-A7C51345-5276-418C-8376-460B38FEDCC4Q37701367-852FB4A9-E0C0-4C9F-B802-FB0C27C3B2A5Q38013666-563AF0D7-98DD-4ED2-A435-39D3B2666E4CQ38113483-E85D3DBF-B7A8-4956-B9F0-E115C32C0E25Q38527557-8CCF010A-F44B-4BBC-9924-00948CE9D483Q39853866-756794B6-977B-49C7-B1B0-EAE9DEEBE8A8Q45849904-153B4DF1-6437-4E1B-B788-ED1818A08644Q48447356-2B43DA08-4E3B-4331-809F-913FF898C4EA
P2860
Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Recombinant activated coagulat ...... ated intracerebral hemorrhage.
@en
Recombinant activated coagulat ...... ated intracerebral hemorrhage.
@nl
type
label
Recombinant activated coagulat ...... ated intracerebral hemorrhage.
@en
Recombinant activated coagulat ...... ated intracerebral hemorrhage.
@nl
prefLabel
Recombinant activated coagulat ...... ated intracerebral hemorrhage.
@en
Recombinant activated coagulat ...... ated intracerebral hemorrhage.
@nl
P2093
P2860
P1433
P1476
Recombinant activated coagulat ...... ated intracerebral hemorrhage.
@en
P2093
Christian Foerch
Elizabeth M Van Cott
Frieder Schlunk
Kazuhide Hayakawa
Waltraud Pfeilschifter
P2860
P304
P356
10.1161/STROKEAHA.111.629360
P407
P577
2011-10-13T00:00:00Z